Optimizing MR-Guided Radiotherapy for Breast Cancer Patients

Current research in radiotherapy (RT) for breast cancer is evaluating neoadjuvant as opposed to adjuvant partial breast irradiation (PBI) with the aim of reducing the volume of breast tissue irradiated and therefore the risk of late treatment-related toxicity. The development of magnetic resonance (...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Front Oncol
Main Authors: Groot Koerkamp, Maureen L., Vasmel, Jeanine E., Russell, Nicola S., Shaitelman, Simona F., Anandadas, Carmel N., Currey, Adam, Vesprini, Danny, Keller, Brian M., De-Colle, Chiara, Han, Kathy, Braunstein, Lior Z., Mahmood, Faisal, Lorenzen, Ebbe L., Philippens, Marielle E. P., Verkooijen, Helena M., Lagendijk, Jan J. W., Houweling, Antonetta C., van den Bongard, H. J. G. Desiree, Kirby, Anna M.
Formato: Artigo
Idioma:Inglês
Publicado: Frontiers Media S.A. 2020
Assuntos:
Oncology
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7399349/
https://ncbi.nlm.nih.gov/pubmed/32850318
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.01107
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares